Quebec Deposit Fund Buys New Stake in Gilead Sciences
Caisse de depot et placement du Quebec bought 2,083,390 shares of Gilead Sciences worth about $263.2 million, adding to a new position. Other funds also reported small share changes, while analyst firms adjusted targets: Leerink cut Gilead to market perform and lowered its price objective, and Truist trimmed its target. Needham reaffirmed a buy rating.